26.48
22-11月-24 16:44:58
15 分の遅延
株式
-5.70
-17.71%
本日の幅
26.02 - 31.40
ISIN
N/A
ソース
NASDAQ
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer
04 1 2021 08:30:00 提供 Nasdaq GlobeNewswire